303360 fundamentals

Protia, Inc. engages in the development, manufacturing, and sale of vitro diagnostic medical devices. The firm's products include rapid tests for allergies, animal diagnosis, autoimmune, antibiotic susceptibility, point-of-care (POCT), and cancer, as well as instruments. Its services include protein analysis, liquid-chromatography tandem mas spectrometry (LC-MS/MS), characterization analysis, custom protein service, and analysist request. The company was founded on March 22, 2000 and is headquartered in Seoul, South Korea.